Comparison of injection site reactions and flu-like symptoms between users of peginterferon beta-1a and subcutaneous interferon beta-1a among persons with multiple sclerosis in the New York State Multiple Sclerosis Consortium

被引：0
|
作者：
Vaughn, C. [1 ,2 ,3 ]
Kavak, K. [1 ,3 ]
Bushra, A. [3 ]
Nadeem, M. [3 ]
Zakalik, K. [1 ,3 ]
Teter, B. [1 ]
Weinstock-Guttman, B. [1 ,2 ,3 ]
机构：
[1] New York State Multiple Sclerosis Consortium, Buffalo, NY USA
[2] SUNY Buffalo, Neurol, Buffalo, NY USA
[3] Jacobs MS Ctr Treatment & Res, Buffalo, NY USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1806
引用
收藏
页码：953 / 954
页数：2
相关论文
共 50 条
  • [1] Peginterferon Beta-1a (Plegridy) for Multiple Sclerosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1468): : 1 - 3
  • [2] Can aerobic exercise alleviate flu-like symptoms following interferon beta-1a injections in patients with multiple sclerosis?
    Langeskov-Christensen, Martin
    Kjolhede, Tue
    Stenager, Egon
    Jensen, Henrik Boye
    Dalgas, Ulrik
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 365 : 114 - 120
  • [3] Multiple Sclerosis New Study Data to Peginterferon beta-1a
    不详
    AKTUELLE NEUROLOGIE, 2015, 42 (06) : 376 - 376
  • [4] A Matching-adjusted Indirect Comparison of Clinical Effectiveness of Subcutaneous Peginterferon Beta-1a and Intramuscular Interferon Beta-1a for the Treatment of Relapsing Multiple Sclerosis
    You, Xiaojun
    Scott, Thomas
    Shang, Shulian
    Evilevitch, Vladimir
    Sabetella, Guido
    Werneburg, Brian
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 415 - 415
  • [5] A Matching-adjusted Indirect Comparison of Clinical Effectiveness of Subcutaneous Peginterferon Beta-1a and Intramuscular Interferon Beta-1a for the Treatment of Relapsing Multiple Sclerosis
    Scott, Thomas
    Shang, Shulian
    Castrillo-Viguera, Carmen
    NEUROLOGY, 2017, 88
  • [6] Subcutaneous Interferon Beta-1a in Pediatric Multiple Sclerosis: A Retrospective Study
    Tenembaum, Silvia N.
    Banwell, Brenda
    Pohl, Daniela
    Krupp, Lauren B.
    Boyko, Alexey
    Meinel, Michael
    Lehr, Lorenz
    Rocak, Sanda
    di Cantogno, Elisabetta Verdun
    Moraga, Margaretha Stam
    Ghezzi, Angelo
    JOURNAL OF CHILD NEUROLOGY, 2013, 28 (07) : 849 - 856
  • [7] Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a
    Pohl, D
    Rostasy, K
    Gärtner, J
    Hanefeld, F
    NEUROLOGY, 2005, 64 (05) : 888 - 890
  • [8] PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
    Gitlin, M.
    Snyder, S.
    Jhaveri, M.
    VALUE IN HEALTH, 2019, 22 : S746 - S746
  • [9] PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN
    Gitlin, M.
    Snyder, S.
    Jhaveri, M.
    VALUE IN HEALTH, 2019, 22 : S744 - S744
  • [10] Can aerobic exercise alleviate flu-like symptoms following interferon beta-1a injections in patients with multiple sclerosis? Preliminary results
    Langeskov-Christensen, M.
    Dalgas, U.
    Stenager, E.
    Jensen, H. Boye
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (04) : 525 - 525
12345